DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE

<p>The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists...

Full description

Bibliographic Details
Main Author: S. Y. Martsevich
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/386
id doaj-3c2c40d170ca45c2bf24429590072aae
record_format Article
spelling doaj-3c2c40d170ca45c2bf24429590072aae2020-11-25T00:19:08ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-12-0131555910.1234/1819-6446-2007-1-55-59386DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USES. Y. Martsevich0Государственный научно-исследовательский центр профилактической медицины Роздрава, Москва<p>The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern recommendations on treatment of arterial hypertension and ischemic heart disease is defined. The clinical importance of differences between various presentations of dihy-dropyridine calcium antagonists is stressed.</p>http://www.rpcardio.ru/jour/article/view/386антагонисты кальциядигидропиридинысердечно-сосудистые осложненияартериальная гипертонияишемическая болезнь сердца
collection DOAJ
language English
format Article
sources DOAJ
author S. Y. Martsevich
spellingShingle S. Y. Martsevich
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
Racionalʹnaâ Farmakoterapiâ v Kardiologii
антагонисты кальция
дигидропиридины
сердечно-сосудистые осложнения
артериальная гипертония
ишемическая болезнь сердца
author_facet S. Y. Martsevich
author_sort S. Y. Martsevich
title DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
title_short DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
title_full DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
title_fullStr DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
title_full_unstemmed DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
title_sort dihydropyridine calcium antagonists: data of evidence based medicine and recom-mendations on practical use
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-12-01
description <p>The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern recommendations on treatment of arterial hypertension and ischemic heart disease is defined. The clinical importance of differences between various presentations of dihy-dropyridine calcium antagonists is stressed.</p>
topic антагонисты кальция
дигидропиридины
сердечно-сосудистые осложнения
артериальная гипертония
ишемическая болезнь сердца
url http://www.rpcardio.ru/jour/article/view/386
work_keys_str_mv AT symartsevich dihydropyridinecalciumantagonistsdataofevidencebasedmedicineandrecommendationsonpracticaluse
_version_ 1725373128880685056